These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2365178)

  • 1. [Fatal fulminant hepatitis in 2 women taking toloxatone (Humoryl)].
    Pateron D; Babany G; Hadengue A; Delafosse B; Degott C; Sylvain C; Larrey D; Benhamou JP
    Gastroenterol Clin Biol; 1990; 14(5):504-6. PubMed ID: 2365178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute toloxatone poisoning. Apropos of 122 cases].
    Azoyan P; Garnier R; Baud FJ; Efthymiou ML
    Therapie; 1990; 45(2):139-44. PubMed ID: 2353326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study.
    Perna G; Cocchi S; Bertani A; Arancio C; Bellodi L
    J Clin Psychopharmacol; 1994 Dec; 14(6):414-8. PubMed ID: 7884022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Auxiliary hepatic transplantation in iproniazid-induced subfulminant hepatitis. Should iproniazid still be sold in France?].
    Maille F; Duvoux C; Cherqui D; Radier C; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1083-5. PubMed ID: 10592880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iproclozide fulminant hepatitis. Possible role of enzyme induction.
    Pessayre D; de Saint-Louvent P; Degott C; Bernuau J; Rueff B; Benhamou JP
    Gastroenterology; 1978 Sep; 75(3):492-6. PubMed ID: 680506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatic injury of monoamine oxidase inhibitors.
    Zimmerman HJ; Ishak KG
    J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of acute ethanol administration on toloxatone pharmacokinetics in rabbits.
    Kaltenbach ML; Vistelle R; Hoizey G; Lamiable D; Zbierski L
    Alcohol Clin Exp Res; 1999 May; 23(5):885-90. PubMed ID: 10371410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of toloxatone in man following intravenous and oral administrations.
    Benedetti MS; Rovei V; Dencker SJ; Nagy A; Johansson R
    Arzneimittelforschung; 1982; 32(3):276-80. PubMed ID: 7200786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toloxatone and depression].
    Fernández Labriola R; Caetano Esquivel G; Alvarez M; Servidio M
    Acta Psiquiatr Psicol Am Lat; 1991 Dec; 37(4):291-8. PubMed ID: 1843597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute hepatic necrosis in a patient treated with cyproterone acetate].
    Lombardi A; Ferrazza P; Castaldi F; Covotta L; Tesoriere A; Urbano V; Midiri G
    G Chir; 1998 Apr; 19(4):161-3. PubMed ID: 9628065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrine.
    Lefebvre H; Richard R; Noblet C; Moore N; Wolf LM
    Lancet; 1993 Feb; 341(8844):555-6. PubMed ID: 8094790
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fulminant hepatitis probably induced by medifoxamine (Cledial)].
    Marnata JB; Lamblin G; Gineston JL
    Gastroenterol Clin Biol; 1991; 15(8-9):659-60. PubMed ID: 1752382
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute hepatitis caused by isaxonine phosphate (Nerfactor)].
    Baud F; Bernuau J; Benmami N; Pariente EA; Bouygues M; Guillan J; Roche-Sicot J; Degott C; Rueff B; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Apr; 7(4):352-4. PubMed ID: 6307799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toloxatone, parkinsonism and dopa therapy].
    Cantagrel A; Dordain G; Dostert P
    Therapie; 1986; 41(6):493-7. PubMed ID: 3810545
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis and pancreatitis due to indalpine].
    Calmus Y; Biour M; Bodin F; Cheymol G; Darnis F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):266-8. PubMed ID: 4007381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoamine oxidase inhibitor in the treatment of attention deficit disorder of residual type. Apropos of a case].
    Parquet PJ; Servant D; Bailly D; Meurice JP
    Encephale; 1988; 14(6):439-41. PubMed ID: 3068049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant hepatitis associated with disulfiram. Report of a case.
    Schade RR; Gray JA; Dekker A; Varma RR; Shaffer RD; Van Thiel DH
    Arch Intern Med; 1983 Jun; 143(6):1271-3. PubMed ID: 6860059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minor and clinically non-significant interaction between toloxatone and amitriptyline.
    Vandel S; Bertschy G; Perault MC; Sandoz M; Bouquet S; Chakroun R; Guibert S; Vandel B
    Eur J Clin Pharmacol; 1993; 44(1):97-9. PubMed ID: 8436164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute amiodarone-induced hepatitis.
    Kalantzis N; Gabriel P; Mouzas J; Tiniakos D; Tsigas D; Tiniakos G
    Hepatogastroenterology; 1991 Feb; 38(1):71-4. PubMed ID: 2026392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis induced by alpidem (Ananxyl). Four cases, one of them fatal].
    Baty V; Denis B; Goudot C; Bas V; Renkes P; Bigard MA; Boissel P; Gaucher P
    Gastroenterol Clin Biol; 1994; 18(12):1129-31. PubMed ID: 7750686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.